| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/J.ZEFQ.2012.10.015 |
| P698 | PubMed publication ID | 23200211 |
| P50 | author | Holger Schünemann | Q28039195 |
| Gerald Gartlehner | Q28320342 | ||
| Joerg J Meerpohl | Q38323848 | ||
| P2093 | author name string | Gero Langer | |
| Alexandra Nolting | |||
| Matthias Perleth | |||
| Angela Kaminski-Hartenthaler | |||
| P2860 | cites work | Why most published research findings are false | Q21092395 |
| Local literature bias in genetic epidemiology: an empirical evaluation of the Chinese literature | Q21563436 | ||
| Selective Publication of Antidepressant Trials and Its Influence on Apparent Efficacy | Q23791313 | ||
| Grey literature in meta-analyses of randomized trials of health care interventions | Q24245582 | ||
| Time to publication for results of clinical trials | Q24245587 | ||
| Misleading data analyses in salmeterol (SMART) study | Q46743806 | ||
| The Salmeterol Multicenter Asthma Research Trial: a comparison of usual pharmacotherapy for asthma or usual pharmacotherapy plus salmeterol | Q46902379 | ||
| In an empirical evaluation of the funnel plot, researchers could not visually identify publication bias. | Q51967379 | ||
| Publication bias and dissemination of clinical research. | Q52867734 | ||
| Fair conduct and fair reporting of clinical trials. | Q52916957 | ||
| Direction and impact of language bias in meta-analyses of controlled trials: empirical study. | Q52938193 | ||
| Language bias in randomised controlled trials published in English and German. | Q53358085 | ||
| Clinical trial registration: a statement from the International Committee of Medical Journal Editors. | Q55038991 | ||
| Estimating Effect Size Under Publication Bias: Small Sample Properties and Robustness of a Random Effects Selection Model | Q56289277 | ||
| Clinical Trial Registration — Looking Back and Moving Ahead | Q57247896 | ||
| Publication Bias: A Problem in Interpreting Medical Data | Q63018176 | ||
| Effect of the statistical significance of results on the time to completion and publication of randomized efficacy trials | Q74121809 | ||
| Pharmaceutical industry sponsorship and research outcome and quality: systematic review | Q24673248 | ||
| The case of the misleading funnel plot | Q24676535 | ||
| Bias in meta-analysis detected by a simple, graphical test | Q24685585 | ||
| Impact of covert duplicate publication on meta-analysis: a case study | Q24685600 | ||
| Operating characteristics of a rank correlation test for publication bias | Q27860653 | ||
| Different patterns of duplicate publication: an analysis of articles used in systematic reviews | Q28246722 | ||
| Reporting bias in drug trials submitted to the Food and Drug Administration: review of publication and presentation | Q28474127 | ||
| Publication bias in clinical research | Q29541186 | ||
| Recursive cumulative meta-analysis: a diagnostic for the evolution of total randomized evidence from group and individual patient data | Q30574153 | ||
| Quinine for nocturnal leg cramps: a meta-analysis including unpublished data | Q32013656 | ||
| Systematic reviews of evaluations of prognostic variables | Q33806488 | ||
| WHO facilitates international collaboration in setting standards for clinical trial registration | Q34422418 | ||
| Meta-analysis of flavonoids for the treatment of haemorrhoids. | Q34532242 | ||
| Evidence b(i)ased medicine--selective reporting from studies sponsored by pharmaceutical industry: review of studies in new drug applications | Q34534086 | ||
| Meta-analyses of therapies for postmenopausal osteoporosis. II. Meta-analysis of alendronate for the treatment of postmenopausal women | Q34803284 | ||
| Bias in reporting clinical trials | Q35802548 | ||
| Publication bias: evidence of delayed publication in a cohort study of clinical research projects | Q36246225 | ||
| N-acetylcysteine in the prevention of contrast-induced nephropathy: publication bias perpetuated by meta-analyses | Q36713709 | ||
| Factors influencing publication of research results. Follow-up of applications submitted to two institutional review boards | Q36728722 | ||
| Contour-enhanced meta-analysis funnel plots help distinguish publication bias from other causes of asymmetry | Q37185996 | ||
| Empirical assessment of effect of publication bias on meta-analyses. | Q38630464 | ||
| Large trials vs meta-analysis of smaller trials: how do their results compare? | Q40923138 | ||
| Bias in location and selection of studies | Q41694445 | ||
| Bias in meta-analysis detected by a simple, graphical test. Asymmetry detected in funnel plot was probably due to true heterogeneity | Q43149749 | ||
| Controversies surround heart drug study: questions about Vytorin and trial sponsors' conduct | Q46722606 | ||
| P433 | issue | 9 | |
| P407 | language of work or name | German | Q188 |
| P921 | main subject | bias | Q742736 |
| P304 | page(s) | 670-676 | |
| P577 | publication date | 2012-11-03 | |
| P1433 | published in | Zeitschrift für Evidenz, Fortbildung und Qualität im Gesundheitswesen | Q186664 |
| P1476 | title | [GRADE guidelines: 5. Rating the quality of evidence: publication bias]. | |
| P478 | volume | 106 |
| Q35594793 | Comparative effectiveness and safety of screening and counselling interventions conducted by non-physicians and physicians: a systematic review |
| Q30317591 | GRADE guidelines: 12. Developing Summary of Findings tables - dichotomous outcomes |
| Q30317182 | GRADE guidelines: 13. Preparing Summary of Findings tables and evidence profiles - continuous outcomes |
| Q37496567 | Prognostic value of p53 mutation for poor outcome of Asian primary liver cancer patients: evidence from a cohort study and meta-analysis of 988 patients |
| Q90181729 | [GRADE equity guidelines 1: Considering health equity in GRADE guideline development - introduction and rationale] |
| Q92533019 | [GRADE: Using evidence to decision frameworks for adoption, adaptation and de novo generation of trustworthy guideline recommendations - GRADE-ADOLOPMENT] |
Search more.